Any Grade Grade ‡ 3 Leading to dose TEAE TEAE Median time (months) to first reduction AE %% occurrence (Q1, Q3) % Bruisinga Arthralgia Rasha Hemorrhage/ Hematomaa Hypertension Atrial fibrilla- tion/ fluttera 31 21 20 17 16 3 0 1 ,1 2 3 1 ...